Current Neuropharmacology impact factor, indexing, ranking (2024)


Current

Aim and Scope

The Current Neuropharmacology is a research journal that publishes research related to Medicine; Neuroscience; Pharmacology, Toxicology and Pharmaceutics. This journal is published by the Bentham Science Publishers B.V.. The ISSN of this journal is 18756190, 1570159X. Based on the Scopus data, the SCImago Journal Rank (SJR) of Current Neuropharmacology is 1.168.

Also, please check the following important details about Current Neuropharmacology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Current Neuropharmacology Ranking

Impact Factor: 7.708
Total Citations: 7580
SJR (SCImago Journal Rank): 1.168
Quartile: Q1

The Impact Factor of Current Neuropharmacology is 7.708.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: Current Neuropharmacology
Publisher: Bentham Science Publishers B.V.
ISSN: 18756190, 1570159X
Type: journal
Journal Scope: Medicine; Neuroscience; Pharmacology, Toxicology and Pharmaceutics
Country: United Arab Emirates
H-Index: 93
SJR: 1.168
Quartile: Medicine (miscellaneous) (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)

Current Neuropharmacology Indexing

The Current Neuropharmacology is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Current Neuropharmacology Impact Factor 2024

The latest impact factor of Current Neuropharmacology is 7.708.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Current Neuropharmacology Quartile

The latest Quartile of Current Neuropharmacology is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Current Neuropharmacology?

If your research is related to Medicine; Neuroscience; Pharmacology, Toxicology and Pharmaceutics, then visit the official website of Current Neuropharmacology and send your manuscript.

Tips for publishing in Current Neuropharmacology:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.


Final Summary

  • The impact factor of Current Neuropharmacology is 7.708.
  • The Current Neuropharmacology is a reputed research journal.
  • It is published by Bentham Science Publishers B.V..
  • The journal is indexed in UGC CARE, Scopus, SCIE, PubMed.
  • The (SJR) SCImago Journal Rank is 1.168.

Sources: Current Neuropharmacology







Similiar Journals


REGULATORY TOXICOLOGY AND PHARMACOLOGY
ISSN: 0273-2300
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE

ALCOHOL
ISSN: 0741-8329
Publisher: ELSEVIER SCIENCE INC

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
ISSN: 0362-1642
Publisher: ANNUAL REVIEWS

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
ISSN: 1742-7835
Publisher: WILEY

BMC PHARMACOLOGY & TOXICOLOGY
ISSN:
Publisher: BMC

CHEMICO-BIOLOGICAL INTERACTIONS
ISSN: 0009-2797
Publisher: ELSEVIER IRELAND LTD

DRUG AND CHEMICAL TOXICOLOGY
ISSN: 0148-0545
Publisher: TAYLOR & FRANCIS LTD

DRUGS
ISSN: 0012-6667
Publisher: ADIS INT LTD

DRUG SAFETY
ISSN: 0114-5916
Publisher: ADIS INT LTD

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
ISSN: 1382-6689
Publisher: ELSEVIER

Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.